K. Tsuchida

Novel Aspects of Transforming Growth Factor-Beta in Diabetic Kidney Disease

K. Sharma, K. Tsuchida, B. Cronin, 2002, Nephron.

Inclusion bodies of aggregated hemosiderins in liver macrophages

K. Hayashi, H. Goto, M. Ishigami, 2017, Medical Molecular Morphology.

Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells.

K. Sharma, S. Siva, Yanqing Zhu, 2003, Kidney international.

Increased Levels of Vascular Endothelial Growth Factor and Advanced Glycation End Products in Aqueous Humor of Patients With Diabetic Retinopathy

Z. Makita, T. Koike, M. Takeuchi, 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195

Z. Makita, T. Koike, H. Miyoshi, 1999, Diabetologia.

Role of Smad 4 on TGF-– induced extracellular matrix stimulation in mesangial cells

Dunn, K. Sharma, S. Siva, 2010 .

Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders

M. Yamagishi, K. Yoshioka, H. Miyajima, 2010, Journal of Gastroenterology.

Title Measurement of serum hepcidin-25 levels as a potential test for diagnosinghemochromatosis and related disorders

M. Yamagishi, K. Yoshioka, H. Miyajima, 2017 .

Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders

M. Yamagishi, K. Yoshioka, H. Miyajima, 2010, Journal of Gastroenterology.